La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Hugel Gestione

Gestione criteri di controllo 1/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Ji-hoon Sohn

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEO	n/a
Mandato del CEO	6.6yrs
Proprietà del CEO	n/a
Durata media del management	6.6yrs
Durata media del Consiglio di amministrazione	2.3yrs

Aggiornamenti recenti sulla gestione

Recent updates

Are Hugel, Inc.'s (KOSDAQ:145020) Mixed Financials Driving The Negative Sentiment?

Mar 19

What Is The Ownership Structure Like For Hugel, Inc. (KOSDAQ:145020)?

Feb 25

Does Hugel (KOSDAQ:145020) Have A Healthy Balance Sheet?

Feb 04

The Hugel (KOSDAQ:145020) Share Price Has Gained 197%, So Why Not Pay It Some Attention?

Jan 17

Does Hugel's (KOSDAQ:145020) Statutory Profit Adequately Reflect Its Underlying Profit?

Dec 29

Does This Valuation Of Hugel, Inc. (KOSDAQ:145020) Imply Investors Are Overpaying?

Dec 14

How Many Hugel, Inc. (KOSDAQ:145020) Shares Do Institutions Own?

Nov 24

AMMINISTRATORE DELEGATO

Ji-hoon Sohn

6.6yrs

Mandato

Mr. Ji-hoon Sohn has been Chief Executive Officer of Hugel, Inc. since 2018. He served as Co-Chair of the Board of Directors at Hugel, Inc. and serves as its Director since March 2018. He served as Chief E...

Gruppo dirigente

Nome	Posizione	Mandato	Compensazione	Proprietà
Ji-hoon Sohn	CEO & Executive Director	6.6yrs	Nessun dato	Nessun dato
J. T. Kim	MD & CFO	5.6yrs	Nessun dato	Nessun dato
Seonho Han	VP and Chief Sales & Marketing Officer	6.6yrs	Nessun dato	Nessun dato
Soon-Woo Kwon	VP & Chief Production Officer	13.6yrs	Nessun dato	Nessun dato
Jennifer Rho	MD & Chief Strategy Officer	no data	Nessun dato	Nessun dato
Minjong Kang	MD & Head of Marketing	5.6yrs	Nessun dato	Nessun dato
Jihye Song	MD & Head of Cosmetics	6.6yrs	Nessun dato	Nessun dato
Young Mahn Yoo	MD & Chief Production Officer	no data	Nessun dato	Nessun dato

6.6yrs

Durata media

Gestione esperta: Il team dirigenziale di A145020 è esperto e expertise (durata media dell'incarico 6.6 anni).

Membri del Consiglio di amministrazione

Nome	Posizione	Mandato	Compensazione	Proprietà
Ji-hoon Sohn	CEO & Executive Director	6.4yrs	Nessun dato	Nessun dato
Brenton L. Saunders	Non-Executive Chairman of the Board of Directors & Chair of Advisory Board	2.3yrs	Nessun dato	Nessun dato
Michael Keyoung	Non-Executive Director	2.3yrs	Nessun dato	Nessun dato
Patrick Holt	Independent Director	2.3yrs	Nessun dato	Nessun dato
Suh Hur	Non-Executive Director	2.3yrs	Nessun dato	Nessun dato
Tae Hyoung Lee	Non-Executive Director	2.3yrs	Nessun dato	Nessun dato
Seungmin Chee	Independent Director	2.3yrs	Nessun dato	Nessun dato
Suk-yong Cha	Non-Executive Director	1.4yrs	Nessun dato	Nessun dato

2.3yrs

Durata media

51.5yo

Età media

Consiglio di amministrazione esperto: Il consiglio di amministrazione di A145020 non è considerato esperto (durata media del mandato 2.3 anni), il che suggerisce un nuovo consiglio.

Hugel Gestione

Gestione criteri di controllo 1/4

Informazioni chiave

Aggiornamenti recenti sulla gestione

Less than half of directors are independent

Hugel, Inc. Appoints Brent Saunders to its Board of Director

No independent directors

Hugel, Inc., Annual General Meeting, Mar 26, 2021

Recent updates

Consensus EPS estimates increase by 13%

Price target increased by 7.2% to ₩279,444

There's Reason For Concern Over Hugel, Inc.'s (KOSDAQ:145020) Price

Investor sentiment deteriorates as stock falls 16%

Now 25% undervalued

Hugel, Inc. to Report Q2, 2024 Results on Aug 07, 2024

Price target increased by 13% to ₩254,889

Investor sentiment improves as stock rises 21%

Estimating The Intrinsic Value Of Hugel, Inc. (KOSDAQ:145020)

Now 21% undervalued

Now 22% undervalued

Hugel, Inc. to Report Q1, 2024 Final Results on May 09, 2024

Hugel (KOSDAQ:145020) Seems To Use Debt Rather Sparingly

Hugel's (KOSDAQ:145020) Performance Is Even Better Than Its Earnings Suggest

Hugel, Inc. (KOSDAQ:A145020) announces an Equity Buyback for KRW 50,000 million worth of its shares.

Now 23% undervalued

Hugel, Inc.'s (KOSDAQ:145020) 25% Price Boost Is Out Of Tune With Earnings

Calculating The Fair Value Of Hugel, Inc. (KOSDAQ:145020)

Investor sentiment improves as stock rises 19%

Price target increased by 8.7% to ₩201,750

Hugel, Inc. (KOSDAQ:A145020) announces an Equity Buyback for KRW 50,000 million worth of its shares.

Consensus EPS estimates increase by 38%

Price target increased by 8.1% to ₩172,571

Hugel Resubmits BLA for Its Botulinum Toxin, Letybo to the U.S. Fda

Price target decreased by 8.8% to ₩159,250

Hugel, Inc. (KOSDAQ:A145020) acquired additional 3.13% stake in Across Co., Ltd for KRW 9.385 billion.

Investor sentiment deteriorates as stock falls 18%

Price target increased by 7.3% to ₩189,714

Investor sentiment deteriorates as stock falls 18%

Hugel, Inc. (KOSDAQ:A145020) announces an Equity Buyback for KRW 50,000 million worth of its shares.

Now 29% undervalued

Now 20% undervalued

Investor sentiment improved over the past week

Hugel's 'Letybo' First in Korea to Obtain Marketing Approval from Australia

Less than half of directors are independent

Consensus forecasts updated

Investor sentiment improved over the past week

Price target decreased to ₩194,875

Hugel, Inc. Appoints Brent Saunders to its Board of Director

No independent directors

Hugel, Inc. (KOSDAQ:A145020) announces an Equity Buyback for KRW 50,000 million worth of its shares.

Price target decreased to ₩214,889

Investor sentiment deteriorated over the past week

Price target decreased to ₩238,333

Consensus EPS estimates fall by 10%

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Are Hugel, Inc.'s (KOSDAQ:145020) Mixed Financials Driving The Negative Sentiment?

What Is The Ownership Structure Like For Hugel, Inc. (KOSDAQ:145020)?

New 90-day low: ₩174,400

Hugel, Inc. Announces Approval to Launch of Letybo 50U in Prc Market

Hugel, Inc., Annual General Meeting, Mar 26, 2021

Does Hugel (KOSDAQ:145020) Have A Healthy Balance Sheet?

Hugel, Inc. to Report Fiscal Year 2020 Results on Feb 09, 2021

Investor sentiment improved over the past week

New 90-day high: ₩224,700

The Hugel (KOSDAQ:145020) Share Price Has Gained 197%, So Why Not Pay It Some Attention?

Price target raised to ₩251,818

Does Hugel's (KOSDAQ:145020) Statutory Profit Adequately Reflect Its Underlying Profit?

Does This Valuation Of Hugel, Inc. (KOSDAQ:145020) Imply Investors Are Overpaying?

New 90-day low: ₩175,600

How Many Hugel, Inc. (KOSDAQ:145020) Shares Do Institutions Own?

Price target raised to ₩241,515

Price target raised to ₩227,788

Price target raised to ₩211,861

Market bids up stock over the past week

New 90-day high: ₩219,900

New 90-day high - ₩194,600

Hugel, Inc. to Report First Half, 2020 Results on Aug 11, 2020

AMMINISTRATORE DELEGATO